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ABSTRACT 
 
This work introduces two major changes to the conventional protocol for designing plastic antibodies: 
(i) the imprinted sites were created with charged monomers while the surrounding environment was tailored using neutral material; and (ii) the 
protein was removed from its imprinted site by means of a protease, aiming at preserving the polymeric network of the plastic antibody. To our 
knowledge, these approaches were never presented before and the resulting material was named here as smart plastic antibody material (SPAM). 
As proof of concept, SPAM was tailored on top of disposable gold-screen printed electrodes (Au-SPE), following a bottom-up approach, for 
targeting myoglobin (Myo) in a point-of-care context. The existence of imprinted sites was checked by comparing a SPAM modified surface to a 
negative control, consisting of similar material where the template was omitted from the procedure and called non-imprinted materials (NIMs). All 
stages of the creation of the SPAM and NIM on the Au layer were followed by both electrochemical impedance spectroscopy (EIS) and cyclic 
voltammetry (CV). AFM imaging was also performed to characterize the topography of the surface. 
There are two major reasons supporting the fact that plastic antibodies were effectively designed by the above approach: (i) they were visualized for 
the first time by AFM, being present only in the SPAM network; and (ii) only the SPAM material was able to rebind to the target protein and produce a 
linear electrical response against EIS and square wave voltammetry (SWV) assays, with NIMs showing a similar-to-random behavior. The SPAM/Au-
SPE devices displayed linear responses to Myo in EIS and 
SWV assays down to 3.5 mg/mL and 0.58 mg/mL, respectively, with detection limits of 1.5 and 0.28 mg/mL. 
SPAM materials also showed negligible interference from troponin T (TnT), bovine serum albumin (BSA) and urea under SWV assays, showing 
promising results for point-of-care applications when applied to spiked biological fluids. 
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1. Introduction 
 
Antibody-based immunoassays are the most commonly used 
diagnostic tool for the analysis of biomolecules (Borrebaeck, 
2000; Katz and Davis, 2000; Reddy et al., 2011; Rimmer, 1998). 
This is due to the great selectivity and affinity linked to the 
antibody–antigen reactions observed in nature.  Antibody-based 
 
 
assays however show several limitations, such as high production 
costs and low chemical stability (Ruigrok et al., 2011). In the 
presence of organic solvents, or in other non-physiological con- 
ditions such as high temperature, pH and high salt concentration, 
they lose their functionality. 
An alternative approach to natural antibodies in immunoassays 
is to substitute them with synthetic materials displaying similar 
properties (Busi et al., 2004). Molecularly imprinted polymers, 
often referred to as plastic antibodies, are prepared by molecular 
imprinting technology, where a polymer is grown around the 
target molecule. Removal of the target from the polymerized 
matrix creates imprinted sites that match the size and shape of 
 
  
 
the target. Effective imprinted sites are expected to act similarly to 
natural antibodies, rebinding to the target compound with great 
affinity and selectivity. 
Much has been achieved with successful imprinting of small 
size molecules (Chen et al., 2011), but the imprinting of proteins 
is still a challenge (Takeuchi and Hishiya, 2008; Turner et al., 
2006; Whitcombe et al., 2011). Proteins by virtue of their complex 
structure have many potential recognition sites at their surface, 
such as charged amino acids and hydrophobic/hydrophilic 
regions. This makes the creation of molecular imprinted polymers 
with high selectivity challenging, due to possible cross-reactivity 
with proteins with similar charge or hydrophobic/hydrophilic 
structure as the template protein. Overall, the main constraints 
when imprinting proteins include their size, complexity, confor- 
mational flexibility and solubility (Turner et al., 2006). Different 
interact strongly with several points at the outer surface of the 
protein, thus favouring more specific template rebinding. However, 
as far as we are aware, the area surrounding the binding site has 
always been composed of the same material as the binding site, 
itself, which has contributed to non-specific interactions. 
In order to create smart plastic antibody materials (SPAM) of 
enhanced specific binding, this work introduces for the first time 
charged monomers on the binding sites combined with neutral 
monomers in the rest of the polymeric matrix. This concept 
formed the basis for the design of Myo plastic antibodies over 
the gold surface of commercial screen-printed electrodes (Au- 
SPE). Myo is the first cardiac biomarker found in the blood as an 
indicator of cardiac damage, which makes its detection in the first 
hours highly significant. The detection of myo should be made in 
point-of-care, quickly, and with low cost. The most advanced and 
methods have been described so far for protein imprinting 
(Takeuchi  and  Hishiya,  2008;  Turner  et  al.,  2006):  (i)  bulk 
commercially  available  devices  so  far  (Alere  TriageZˇ 
include (always) immunoassay-based reactions. 
Cardiac) 
imprinting, in which the whole protein is imprinted (Katz and 
Davis,  2000;  Savina  et  al.,  2009;  Ye  and  Mosbach,   2001); 
(ii) epitope imprinting, where only the antigenic determinant 
part of the protein is used for imprinting (Bossi et al., 2012; Lass- 
Napiorkowska et al., 2012; Lu et al., 2012) and (iii) surface 
imprinting in which only a part of the surface of the protein is 
imprinted over a planar surface (Moreira et al. 2011a; Moreira  
et al., 2011b; Wang et al., 2008 Yildirim et al., 2012; Liao et al., 
2009). 
Despite its simplicity, bulk imprinting of proteins is today 
recognized as an approach of limited success. It is often associated 
with (i) irregular shape of the imprinted particles, (ii) poor 
template removal by protein entrapment and (iii) restricted 
stereochemical access of the protein to the rebinding sites 
(Whitcombe et al., 2011; Wang et al., 2008). Epitope imprinting 
seems to be a successful strategy (Whitcombe et al., 2011; 
Hillberg and Tabrizian, 2008), but only small to medium sized 
peptides have been imprinted so far and further studies are 
required to obtain unique and freely available epitope sequences 
(Hillberg and Tabrizian, 2008; Whitcombe et al., 2011). 
When an entire protein is to be imprinted, surface imprinting 
is by far the most successful approach. It leads to higher binding 
capacity and faster mass transfer/binding kinetics than traditional 
bulk processes. In  general, surface  imprinting takes  place  in 
4 steps: (i) attachment of the template to the surface; (ii) selection 
of functional monomers showing a special ability to interact 
with the functional groups of the template molecule; (iii) a pre- 
polymerization stage where these monomers are allowed to bind 
to the template molecule, followed by a polymerization step; and 
(iv) template removal, leaving behind cavities that constitute the 
templates comprising of empty rebinding sites. 
Several strategies for surface imprinting have been described 
in the literature. Most of these report the use of immobilized 
template, initiation on the supporting matrix, and combined sur- 
face imprinting with controlled/living free radical polymerization 
(Chen et al., 2011; Shi et al., 1999; Bossi et al., 2007; Shiomi et al., 
2005; Moreira et al., 2011a; Moreira et al., 2011b; Bonini et al., 
2007; Piletsky et al., 2000). In general, the covalent immobilization 
of the template molecules at the surface of solid substrates offers 
some advantages: it enables imprinting templates that are inso- 
luble in the pre-polymerization mixture and minimizes the tem- 
plate aggregation, thus leading to more homogeneous binding sites 
(Chen et al., 2011). 
The monomers selected for creating the surface imprinted 
binding sites are at the core of the success of the plastic antibody 
operation (Andersson, 2000; Kriz et al., 1997; Shi et al., 1999). Due 
to the multiple-charge nature of proteins and their multiple surface 
features, different monomers have been employed, neutral or 
negatively/positively charged. In essence, they are expected   to 
The charged monomers used for this purpose were 2-acryl- 
amido-2-methyl-1-propanesulfonic acid sodium salt (AMPSA) and 
2-aminoethyl methacrylate hydrochloride (AEMA). The neutral- 
surrounding material was obtained by co-polymerizing acrylamide 
(AAm) and N,N0-methylenebisacrylamide (NNMBA). Non-imprinted 
materials (NIM) were produced by removing the template from the 
procedure and the ability of the polymer to interact non-specifically 
with the template was measured. The resulting biosensor was 
evaluated by several electrochemical techniques and further 
applied to the analysis of biological samples. 
 
 
2. Experimental section 
 
2.1. Apparatus 
 
The electrochemical measurements were conducted with a 
potentiostat/galvanostat from Metrohm Autolab and a PGSTAT302N, 
impedimetic module and controlled by Ivium software. Au-SPEs 
were purchased from DROPSENS (DRP-C220AT), having working 
and counter electrodes made of gold and reference electrode and 
electrical contacts made of silver. The diameter of the working 
electrode was 4 mm and the Au-SPEs were placed in a switch box 
(DROPSENS), interfacing the electrical contacts of the Au-SPE with 
the electrical connections of the potentiostat/galvanostat. 
 
2.2. Reagents 
 
All chemicals were of analytical grade and water was de-ionized 
or ultrapure Milli-Q laboratory grade. Potassium hexacyanoferrate III 
(K3[Fe(CN)6]) and potassium hexacyanoferrate II (K4[Fe(CN)6]) 
trihydrate were obtained from Riedel-deHaen; AAm, NNMBA, TnT, 
BSA, urea, and sodium chloride from Fluka; AMPSA, thiomalic acid 
(TMA) and AEMA from Aldrich; and Myo, N-hydroxysuccinimide 
(NHS), N-ethyl-N0-(3-dimethylaminopropyl) carbodiimide hydro- 
chloride (EDAC), and Benzoyl Peroxide (BPO) from Himedia. 
 
2.3. Solutions 
 
Stock solutions of 5.0 x 10- 6 mol/L Myo were prepared in MES 
buffer (1.0 x 10- 2 mol/L, pH 4.5). Less concentrated standards were 
obtained by accurate dilution of the previous solution in the same 
buffer. Electrochemical assays were performed with 5.0 x 10- 3 mol/L 
K3[Fe(CN)6]  and  K4[Fe(CN)6]  in  MES  1.0 x 10
- 3 mol/L,  pH  4.5. 
The selectivity study used 2.0 x 10- 7 mol/L Myo solutions prepared 
in buffer and solutions of possible interfering species, TnT (2.0 x 
10- 7 mol/L),  BSA  (2.0 x 10- 7 mol/L),  and  urea  (2.0 x 10- 7 mol/L), 
prepared in the same buffer. 
  
 
2.4. Design of the plastic antibody on the  Au-SPE 
 
The gold surface of the working electrode was thoroughly 
washed with de-ionized water and incubated in 10 mmol/L 
solutions of TMA for 20 h, at 25 1C, previously. After this stage, 
all modifying solutions were applied subsequently and only   on 
the working electrode area, by placing on it a 5 mL drop of   the 
corresponding  solution. 
The carboxylic acid groups on the gold surface (Au-SPE/TMA) 
were activated by reaction with EDAC 50 mmol/L and 25 mmol/L 
NHS, and washed after with deionized water. The modified 
electrode  was  then  incubated  in  Myo  solution  1 x 10- 4 mol/L, 
prepared in PBS buffer, pH 7.0, for 2.5 h, at 4 1C. The SPE modified 
with Au/TMA/Myo was then thoroughly washed again with PBS 
buffer and ultrapure water to remove adsorbed Myo. 
The imprinting stage started by incubating overnight the Au- 
SPE/TMA/Myo    electrode    in    5.0 x 10- 4 mol/L    AMPSA    and 
 
BSA, or urea, solutions of the same concentration. All these were 
prepared in MES buffer pH 4.5. 
The standard addition method was applied to determine Myo 
in spiked serum samples with a BSA concentration. Myo concen- 
tration was set to 45 mg/mL. This solution was further diluted to 
achieve Myo levels from 0.59 to 18.77 mg/mL, lying within the 
linear range of the device. 
 
2.7.   Binding isotherm 
 
The rebinding properties of Au-SPE/TMA/SPAM biosensor were 
measured by calculating the apparent dissociation constant (KD) 
through SWV assays. KD was the protein concentration required 
to give half of the maximum response produced by the device. 
This was done by fitting to the Langmuir isotherm (Eq. (1)) where 
IS  was  the  normalized  current-density  (in  Acm- 2),  S,  the  con- 
centration of Myo (in mol/L) and Imax, the maximum current 
5.0 x 10- 4 mol/L  AEMA.  This  was  followed  by  the  addition  of 
5.0 x 10- 4 mol/L   AAm   (monomer),   5.0 x 10- 5 mol/L   NNMBA 
density observed (in Acm- 2). 
(cross-linker) and 5.0 x 10- 4 mol/L BPO (initiator) solutions. The 
polymerization was carried out at 25 1C for 5 h. The resulting 
material, Au-SPE/TMA/Myo/polymer, was thoroughly washed 
with deionized water and incubated overnight in protease K, 
 
 
400 mg/mL, prepared in PBS buffer, pH 7.4, in the dark, to remove 
the protein template. The resulting material without template, 
Au-SPE/TMA/SPAM, was then washed several times in PBS buffer 
to remove protein fragments and proteinase K, and finally rinsed 
with MQ water (Zayats et al., 2011). 
Blank materials of SPAM were produced in parallel, where the 
protein was removed from the synthetic pathway. These were 
named NIM (non-imprinted materials) and were used to evaluate 
the imprinting effect, because no specific binding sites should 
exist on it. 
 
2.5. AFM analysis 
 
The SPAM/NIM surfaces were characterized using atomic force 
microscopy. Two different modes of AFM were tried to character- 
ize the surface of the electrodes. These were tapping mode 
(Veeco Metrology Multimode/Nanoscope IVA) and contact mode 
(Nanoink NScriptor based AFM with A type tips). AFM images 
from tapping mode were found better and Image J software was 
used to analyze these. 
 
2.6. Electrochemical procedures 
 
CV and SWV measurements were conducted in 5.0 mmol/L 
of [Fe(CN)6]
3 -  and 5.0 mmol/L of [Fe(CN)6]
4 - , prepared in MES 
buffer, pH 4.5. For CV assays, the potential was scanned from 
-0.6  to  þ0.7 V,  at  50 mV/s.  In  SWV  studies  potentials  were 
changed  from  -0.6  to  þ0.6 V,  at  a  frequency  of  50 Hz  with  a 
step height of 150 mV. All assays were conducted in triplicate. 
EIS assays were also conducted in triplicate with the same 
redox couple [Fe(CN)6]
3 - /4 - at a standard potential of þ0.12 V, 
using a sinusoidal potential perturbation with an amplitude of 
0.01 V and the number of frequencies equal to 50, logarithmically 
distributed over a frequency range of 0.1–100 kHz. The impe- 
dance data were fitted to a Randles equivalent circuit using the 
implemented Ivium software. 
Calibration curves were determined for Myo   concentrations 
between 0.0250 and 41.1 mg/mL. The time given for SPAM/Myo 
interaction was set to 5 min. The response of the sensor was 
reversed after cleaning with proteinase K for 12 h and subsequent 
washing with PBS and water. 
Selectivity studies were conducted by competitive assay 
between  Myo,  with  a  2.0 x 10- 7 mol/L  concentration,  and  TnT, 
3. Results and discussion 
 
3.1. SPAM design 
 
The preparation of SPAM involved a bottom-up approach   of 
4 stages, as indicated in Fig. 1. It started by assembling a 
carboxylic layer on top of the gold working electrode of the SPE. 
This layer was activated for covalently binding Myo. The imprint- 
ing stage started by positioning the charged-monomers on the 
pre-polymerization mixture and polymerizing the vacant sites 
around the protein with neutral monomer and cross-linker 
species. The imprinted sites were finally obtained once the 
protein was removed. 
In detail, the carboxylic layer was formed first by incubating 
the Au-SPE in TMA (Fig. 1A). The contact of TMA with a clean gold 
substrate led to the spontaneous formation of a closely packed 
monolayer via a strong gold–sulfur interaction between the thiol 
group (–SH) and Au. The carboxylic groups pointing outside were 
then activated, aiming at binding the protein afterwards under 
near-to-physiological conditions. This was done by EDAC/NHS 
chemistry. This reaction is well known, forming a highly reactive 
O-Acylisourea intermediate that reacts quickly with NHS to 
produce a more stable succinimydyl ester intermediate (Jiang  
et al., 2004). This ester undergoes nucleophilic substitution with 
any readily available amine group (on Myo), resulting in the 
formation of an amide bond between the  ester  and  protein 
(Fig. 1B). 
The rebinding cavities expected to display a similar-to- 
antibody behavior started being formed by self-organizing the 
charged-monomers around the protein. Each charged monomer 
would be bound by ionic interaction to a Myo residue of opposite 
charge located on the protein surface. By taking part in the 
subsequent polymerization stage, these monomers would remain 
in position within the final SPAM structure (Fig. 1C). The selection 
of the most suitable monomers for this purpose depended on the 
nature of the organic functions of Myo pointing towards the 
surrounding environment. Myo has many kinds of amino acid 
residues along its polypeptide chain of 153 amino acids, distrib- 
uted over a globular and compact form (45 x 35 x 25 A˚ ). The exact 
amount and nature of the residues on the outer surface are 
however difficult to predict because proteins are not rigid objects 
and their biological function is controlled by conformational 
changes of different magnitudes (Brunori et al., 2004). So,   one 
  
 
 
Fig. 1. Schematic representation of the synthetic process of SPAM. (A) Au-SPE modified with TMA and producing a carboxylic layer; (B) Myo immobilized on the activated 
carboxylic groups of Au-SPE/TMA; (C) charged-monomers in position and blocked carboxylic functions that remained active; (D) polymerization with neutral monomer 
structures around the template; and (E): binding site formation by template removal with proteinase   K. 
 
may say that both charged and uncharged polar amino acid side- 
chains are expected to be directed towards the external surface 
of the protein. Consequently, both positively and negatively 
charged-monomers were used, contributing to an increasing 
number of interactions, and thus to a more accurate stereoche- 
mical recognition of the protein template. 
Monomers with amine (AEMA) and sulfonic acid (AMPSA) 
based functions were selected (Fig. 1C). Although they are not 
completely ionized in solution, they ensure physiological compat- 
ibility with the target protein, granting that its conformation is 
kept. Only the ionized fraction of these monomers interacting 
with Myo is expected to contribute to the imprinted site because 
weakly bound monomers were removed by washing the material 
with water after positioning the monomers. This was indeed an 
essential condition to ensure that only neutral monomers would 
take part in the subsequent polymerization stage (thus avoiding 
any polymerizable charged species outside the binding site area). 
In addition, the non-ionized fraction of the amine function also 
blocked the carboxylic functions remaining active after protein 
binding, thus avoiding side-reactions with the material and 
ensuring that the subsequent polymeric fraction would remain 
attached to the modified gold surface. 
The position of the charged groups was set firm by polymeriz- 
ing the vacant area around the protein (Fig. 1D). This was done by 
an addition reaction where all vinyl groups from monomer and 
cross-linker species gave rise to long branched carbon chains. 
Only amide functions were present in the final reticulated 
material because this was the only organic function in AAm and 
NNMBA monomers. A radical initiation of the polymerization was 
preferred (by using BPO) to cationic or anionic ones, because 
these would introduce a greater number of charged species inside 
the polymeric matrix. This matrix was firstly designed to be 
neutral outside the binding sites, and this was an essential 
condition to reduce non-specific-binding. 
The SPAM material was ready after removing the template 
from its imprinted site (Fig. 1D). Many different approaches have 
been used for this purpose (Whitcombe et al., 2011; Zdyrko et al., 
2009) and the use of a proteolytic enzyme is unique in this regard. 
This procedure was aimed at ensuring the complete removal of 
the protein and keeping mild conditions to avoid any disturbance 
around the SPAM network. Proteinase K was the enzyme selected 
for this purpose. It cleaved peptide bonds, converting each 
accessible single polypeptide from Myo into smaller peptide 
fragments. These fragments were removed from the cavity by 
rinsing the material with buffer. 
 
3.2. Control of the surface modification by impedance and 
voltammetry measurements 
 
The modification of metal surfaces with organic films produces 
global modifications in its electrical features. These can be 
measured by monitoring the changes in the electron transfer 
properties  of  well-known  redox  systems,  such  as  [Fe(CN)6]
4 -/ 
[Fe(CN)6]
3 -. Indirect ways of measuring such alterations include 
EIS and CV assays. 
EIS studies were used to follow the Au-SPE modification after 
each chemical change. Randle’s equivalent circuit was adopted to 
model the physiochemical process occurring at the gold electrode 
surface as it is frequently used to interpret simple electrochemical 
systems. The elements of this circuit included the uncompensated 
resistance of the solution phase (RS), the capacitance of the double 
layer (Cdl), and charge-transfer resistance (Rct) which is inversely 
proportional to the rate of electron transfer, and the Warburg 
diffusion element (W), accounting for the diffusion of ions from 
bulk electrolyte to the electrode interface. 
The obtained EIS spectra are presented as Nyquist plots in Fig. 2. 
In general, the semicircle was observed at high frequency range 
and indicated a charge-transfer controlled process. The diameter of 
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Fig. 2.  Electrochemical study over the subsequent modification steps of the Au-SPE in 5.0 mM [Fe(CN)6]
3 -  
and 5.0 mM [Fe(CN)6]
4 -
, in MES buffer pH 4.5, carried out by 
EIS (A, Nyquist plots) and CV (B, cyclic voltammograms) assays for SPAM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Electrochemical EIS spectra (A) and CV voltammograms (B) of the NIM-surfaces after polymerization and proteinase K treatment stages (evaluated in 5.0 mM 
[Fe(CN)6]
3 -  
and 5.0 mM [Fe(CN)6]
4 -
, in MES buffer pH 4.5). 
 
this semicircle equaled Rct, controlling the electron transfer kinetics 
of the redox-probe at the electrode interface (Panagopoulou et al., 
2010). The linear arm was seen in the low frequency range and 
showed  diffusion-controlled mass-transfer. 
The bare gold surface showed a very small semicircle domain, 
suggesting a very fast electron-transfer process with a diffusional 
limiting step (Fig. 2A). Modification with the TMA monolayer gave 
rise to subsequent increases in the electron transfer resistance, 
resulting in increases in the semicircular section of the Nyquist 
plot. For SPAM polymer (Fig. 2A), further linkage of Myo followed 
by the polymerization stage produced additional barriers for the 
redox probe access to the Au-SPE modified electrode. This 
resulted in an extra increase in the electron transfer resistance, 
reflected by further substantial increase in Rct. The final step of 
the artificial antibody synthesis was the template removal with 
proteinase K. In this step the resistance decreased (Fig. 2A), 
suggesting that Myo was successfully extracted from the polymer. 
No resistance decrease was observed on NIM after proteinase  K 
treatment (Fig. 3A), which accounted for the stability of the 
polymer network against the enzyme. The Rct of the NIM materi- 
als (Fig. 3A) was close to that of SPAM material without template 
(Figure S1-A), thus suggesting that the template removal step was 
efficient. 
CV assays shown in Figs. 2B, 3B, and S1-B supported the 
previous studies of EIS. The modifications of the bare gold up to 
the polymerization stage increased the peak-to-peak potential 
separation and decreased the peak height of the redox probe in 
the voltammograms, thus accounting for the increased Rct. This 
behavior was reversed after the template removal, accounting for 
the absence of the protein and the polymer porosity. 
 
3.3. AFM analysis 
 
Although electrical characterization was done on SPEs, surface 
characterization studies were conducted only on planar gold 
surfaces employed in regular surface plasmon resonance  (SPR) 
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Fig. 4. AFM tapping mode images showing 300 nm x 300 nm scan after proteinase K treatment of (A) NIM and (B) SPAM surfaces. AFM images processed using the 
Nanorule program to show the 3-dimensional  topography. 
 
 
measurements. SPAM and NIM materials were assembled on the 
SPR planar gold chips following the same procedure as that 
described for the SPEs. 
Clear differences were observed between the images of NIM 
and SPAM structures (Fig. 4). Only SPAM material showed cavities 
(these were never present in the NIM material), attributed to the 
plastic antibodies. About 90% of these cavities ranged   between 
3.5  and  10 nm.  Considering  that  a  single  Myo  molecule  is 
4.5 nm x 3.5 nm x 2.5 nm (Lin et al., 2007), this indicated that 
under the imprinting conditions Myo existed both in monomeric 
and dimeric states. In addition, the pores of the acrylamide gels 
range between 21 and 200 nm (Stellwagen, 1998) which indi- 
cated that the AFM images obtained from tapping modes were in 
fact cavities in the template. A good correlation with the electro- 
chemistry data further confirms this observation. 
 
3.4. Analytical performance of the sensor 
 
The analytical performance of Myo sensory materials was 
evaluated by recording calibration curves in EIS and SWV mea- 
surements (Fig. 5). Among other voltammetric methods, SWV 
offers the advantages of high sensitivity to surface-confined 
electrode reactions, along with suitable detection capabilities 
and rapidity. EIS readings may be straightforward for low cost 
and on-site analysis. 
EIS calibration curves plotted the Rct of SPAM or NIM Au-SPE 
sensors against logarithm Myo concentration (Fig. 5A). Increasing 
concentrations of Myo increased the diameter of the semicircles 
in the Nyquist plots (Figure S2-A), indicating that Myo bound to 
the sensory layer increased the charge-transfer resistance of the 
probe. This was as expected from the previous EIS studies, 
accounting for an increased Rct when Myo was bound to the 
sensing material and a decreased Rct when Myo was removed 
from  it.  The  typical  calibration  plot  of  SPAM  sensors shows 
linear behavior down to 3.5 mg/mL, with an average slope of 
461.4 O/decade [Myo, mg/mL] and squared correlation coeffi- 
cients 40.999. The detection limit was 1.5 mg/mL, corresponding 
to the concentration of the cross-section of the two linear parts of 
the response function (Buck and Lindner, 1994). The average and 
the relative standard deviation of the blank were 300 and 14  O, 
respectively. The standard deviation of repeated assays was o5%. 
In SWV assays, Myo binding was revealed by a decrease in the 
typical anodic peak current of redox probe solutions (Figure S2-B). 
Higher Myo concentrations yielded smaller peaks. A linear pat- 
tern against Log[Myo] was observed for concentrations down  to 
0.58 mg/mL (Fig. 5B), a value that lies within the  physiological 
levels expected by the first hour after cardiac damage. This linear 
behavior was observed up to 0.58 mg/mL. The limit of detection 
was calculated similarly to EIS studies, and was equal to 0.28 mg/mL. 
The  average  and  the  standard  deviation  of  the  blank   were 
74.0 and 3.7 mA, respectively. The relative standard deviation of 
repeated assays was o5%. 
The NIM sensor displayed an inconsistent response over the 
range of the calibration curves, both  in  EIS  and  SWV  assays  
(Fig. 5A and B). These results indicated that the non-specific inter- 
action (the only kind existing in NIM surfaces) between the template 
and polymer did not control the electrochemical response. Only 
monomers polymerized in the presence of a template should    have 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.  Calibration curves of SPAM and NIM based Au-SPE biosensors obtained by EIS (A) and SWV (B) measurements in 5.0 mM [Fe(CN)6]
3 -  
and 5.0 mM [Fe(CN)6]
4 -
, in 
MES buffer pH 4.5, with different concentrations of Myo (in mg/mL). Coefficient of variation of presented data o 5%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Graphical representation of the Langmuir isotherm plot (A) for SPAM (with Imax and KD values) and NIM materials, and the selectivity data for Tnt (B). 
 
imprinted sites, and these sites are clearly controlling the interaction 
between Myo and SPAM. 
 
3.5. Binding isotherm 
 
The calibration of the SPAM biosensor in SWV follows a 
hyperbolic response (Fig. 6A) approaching the typical behavior 
of antibody/antigen interactions (Moreira et al., 2011b; Yildirim 
et al., 2012). The parametric data over the Langmuir equation 
(Imax and KD in Eq. (1)) assess the biosensor performance in terms 
of template rebinding. Imax reflects the differences in the amount 
of Myo bound to the sensor surface and KD (the dissociation 
constant) shows the concentration of template providing half of 
the maximum response (Imax), thus measuring how well Myo 
complexes with the plastic antibody material and the affinity 
with which it occurs. If the KD is low it indicates a large binding 
affinity, as the reaction will approach the maximum response 
more rapidly. On the contrary, a high KD indicates that the plastic 
anibody does not bind as efficiently with the Myo, and only 
higher concentrations of Myo are able to saturate the response of 
the plastic antibody surface. In general, changes in KD are 
sensitive to variations in protein access/binding (Sasso et al., 
1990; Rothwell et al., 2010) and may be interpreted here in terms 
of barriers to antigen–artificial antibody access. 
Fitting the data to a hyperbolic function (Langmuir), where 
(I*–I) represents the binding adsorption for each concentration 
value of Myo and I* the maximum current observed in all ranges 
of  concentration  studied,  gave  values  of  KD ¼ 3 70.5 mM  and 
Imax ¼ 44 72 nA with a chi-square of 26.5 for the SPAM (Fig. 6A). 
The NIM binding data did not fit to the Langmuir model, since a 
chi-square of 556 was obtained. Overall, these results showed 
that the SPAM sensor displayed much higher affinity to Myo than 
NIM, showing a controlled/predictable response against Myo 
concentration. Since the differences between NIM and SPAM are 
only the absence/presence of Myo tailored sites on the receptor 
structure, respectively, the above observations pointed out that 
the non-specific interaction has been majorly reduced by intro- 
ducing the charged monomers upon the binding sites. 
EIS, calibration SWV, Calibration 
1000 75 
900 
800 
700 
600 
500 
400 
300 
200 
100 
-2.0 
Rct = 525.78 x log [Myo] + 106.29 
R2= 0.9904 60 
-- SPAM 45 
-- NIM 
30 
I=-25.3 x log [Myo]+44.0 
R2= 0.9901 
15 
-1.0 0.0 
Log [Myo, g/mL] 
1.0 2.0 -2.0 -1.0 0.0 
Log [Myo, g/mL] 
1.0 2.0 
0 
Binding Selectivity, TnT 
50 
I max 
40 
 
30 
120 
100 
80 
60 
40 
20 
0 
20 
Myo    Myo+TnT 
SPAM 
10 
--- NIM 
Myo 
Myo + TnT 
0 
0   KD 10 20 30 
Myo, g/mL 
-0.3  -0.2  -0.1   0    0.1   0.2   0.3   0.4   0.5  0.6 
Potential (V) 
R
ct
,

I*
-I
, 

A
 
R
e
la
ti
v
e
 C
u
rr
e
n
t 
(%
) 
-9
. 
0
%
 
2
0
 
A
 
C
u
rr
en
t,
 
A
 
  
 
3.6. Selectivity study 
 
The selectivity of the sensor is of great importance for a 
successful analytical application and was evaluated by SVW 
measurements. The interfering species tested were selected 
among those that may be found in biological fluids, such as TnT, 
BSA (serum), and urea (urine). 
A competitive assay was used to test their interference in    a 
2.0 x 10- 7 mol/L Myo solution. For this purpose, the response of 
the SPAM sensors was checked for solutions having only Myo or 
Myo þinterfering species, where a competition between Myo and 
interfering species for the same binding sites was established.  
A 5 min contact between the SPAM surface and each solution was 
allowed. Each assay was conducted in a different Au-SPE/SPAM 
sensor, in order to avoid a cross contamination from previously 
adsorbed Myo or interfering compound. 
The average % deviation produced by each interfering species 
in pure Myo solutions were 6.0% for TnT, 10.9% for BSA and 8.7% 
for urea. A typical voltammogram with the corresponding average 
% deviation for TnT may be seen in Fig. 6B, and the others are 
shown as supplementary material (Figure S3). The relative stan- 
dard deviation of repeated assays was o5%. 
3.7. Myo assay 
 
The standard addition method was applied to determine Myo 
in spiked diluted serum samples having Myo concentrations 
ranging from 0.59 to 18.77 mg/mL Myo. This was performed  in 
triplicate by SWV measurements. A good agreement was found 
between added and found amounts of Myo, with recoveries lying 
within 94% and 97% respectively. The relative standard deviation 
obtained  for  reproduced  assays  was  o5.8%  and  for  repeated 
assays  o5%,  thus  confirming  the  good  precision  of  this  new 
analytical approach. These results show great expectations 
around this SPAM network, also acting as a promising tool for 
direct applications in point-of-care context. 
 
 
4. Conclusions 
 
Compared to previous Myo plastic antibodies described in the 
literature (Moreira et al., 2011b; Wang et al., 2008), this is the 
first time an imprinted material is able to recognize the target 
protein mostly by its specific binding sites. As far as we are aware 
this is the first time that a non-imprinted polymer showed an 
absence of dose response behavior with a target molecule protein, 
consistent with the non-specific binding to the polymer being 
minimal. Furthermore, we believe that it is the first time that the 
imprinted sites are seen in the AFM images, showing cavities   
of a comparable size to the imprinted protein or only small 
aggregates. 
Overall, it seems that the SPAM approach proposed here 
concerning the use of charged-monomers offers a promising 
alternative to the design of new surface confined plastic anti- 
bodies for proteins. Although the limit of detection provides proof 
of concept for using the device in point-of-care context, further 
developments will be necessary for practical application in a 
clinical setting. 
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